Bluejay Diagnostics, Inc. announced it has met a critical contractual milestone by establishing a manufacturing site for its Symphony™ diagnostic cartridges. This development, achieved ahead of schedule under an agreement with Toray Industries, is part of the company's strategy to build a resilient, dual-pathway supply chain as it prepares for regulatory submission and potential commercialization.
Key Details
- Milestone Achieved: The company fulfilled its obligation under an amended license agreement with Toray Industries, Inc. by establishing the manufacturing site ahead of the October 23, 2026 deadline.
- Manufacturing Partners: The strategy utilizes complementary capabilities from SanyoSeiko Co., Ltd. in Japan (fulfilling the Toray milestone) and ALURIS Sciences in the U.S. to ensure supply-chain resilience and redundancy.
- Commercial Readiness: This is a key step in reducing business and commercial execution risk as Bluejay advances its Symphony™ IL-6 Test, its first product candidate, toward regulatory submission.